Understanding Acute HFpEF (Acute Heart Failure with Preserved Ejection Fraction) is crucial for accurate clinical documentation and medical coding. This page provides information on Acute Diastolic Heart Failure, including diagnosis criteria, treatment options, and ICD-10 codes relevant to Acute HFpEF for healthcare professionals. Learn about managing and documenting Acute Heart Failure with Preserved Ejection Fraction in a clinical setting.
Sudden worsening of heart function with normal ejection fraction (ability to pump blood out).
Shortness of breath, fatigue, edema (swelling), rapid heart rate, lung congestion.
Hospitalization due to infection, uncontrolled hypertension, or new-onset atrial fibrillation.
Complete code families applicable to I50.31
| Description | When to use |
|---|---|
| Sudden worsening of heart failure with normal EF. | Acute onset of HF symptoms, EF >= 50%, diastolic dysfunction evidence. |
| Chronic heart failure with normal EF. | Persistent HF symptoms, EF >= 50%, diastolic dysfunction evident. Exclude acute causes. |
| Acute heart failure with reduced EF. | Acute HF symptoms, EF < 40%, systolic dysfunction evident. |
Insufficient documentation of EF, impacting accurate coding and differentiation from HFrEF.
Lack of clear documentation supporting the acute nature of HFpEF, leading to potential downcoding.
Missed or inaccurate coding of comorbidities contributing to HFpEF, affecting severity and reimbursement.
1. LVEF >=50%: Verify preserved ejection fraction via echocardiogram.
2. Symptoms of HF: Dyspnea, edema, fatigue documented?
3. Diastolic dysfunction: Evidence from echo or other imaging?
4. Exacerbating factors: Infection, ischemia, arrhythmia noted?
5. Optimize coding: I50.31, I50.33, I50.41, I50.43 considered?
Patient presents with acute heart failure with preserved ejection fraction (HFpEF), also known as acute diastolic heart failure. Symptoms include acute onset of dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Physical examination reveals elevated jugular venous pressure, pulmonary rales, and an S3 heart sound. The patient's left ventricular ejection fraction (LVEF) is greater than or equal to 50% on echocardiography, confirming preserved systolic function. Diastolic dysfunction is evident on echocardiography with impaired left ventricular relaxation and elevated filling pressures. The patient's medical history includes hypertension and diabetes mellitus, both risk factors for HFpEF. Differential diagnosis includes acute coronary syndrome, valvular heart disease, and pulmonary embolism. Laboratory tests, including BNP and troponin, were ordered to aid in diagnosis and risk stratification. Initial treatment includes intravenous diuretics for symptom relief and management of pulmonary congestion. Optimization of chronic heart failure medications, including blood pressure control and diabetes management, will be addressed. The patient's prognosis and treatment plan will be discussed, including the importance of lifestyle modifications such as sodium restriction and fluid management. Follow-up with cardiology is scheduled for further evaluation and optimization of heart failure therapy. ICD-10 code I50.31, heart failure with preserved ejection fraction, is recorded for this encounter. This documentation supports medical billing and coding for appropriate reimbursement.
Differentiating acute HFpEF from acute decompensated HFrEF in a patient with dyspnea and pulmonary edema can be challenging as both present with similar symptoms. Key differentiating factors include assessment of left ventricular ejection fraction (LVEF). HFpEF is defined by an LVEF >= 50%, while HFrEF is characterized by an LVEF < 40%. Other clinical clues suggestive of HFpEF include a history of hypertension, diabetes, atrial fibrillation, and preserved stroke volume. Physical exam findings like elevated jugular venous pressure, S4 gallop, and pulmonary rales can be present in both. Echocardiography is crucial for assessing diastolic function and confirming the diagnosis. While both may require diuresis for pulmonary edema, the long-term management strategies differ significantly. Explore how S10.AI can aid in the differential diagnosis of acute heart failure presentations.
Initial management of acute HFpEF exacerbation in the emergency department focuses on optimizing oxygenation and hemodynamics. Supplemental oxygen should be administered to maintain SpO2 above 90%. Intravenous diuretics, such as furosemide or torsemide, are the cornerstone of therapy for managing fluid overload and pulmonary congestion. Careful monitoring of electrolyte imbalances, particularly potassium and magnesium, is crucial during diuresis. For patients with hypotension or evidence of cardiogenic shock, consider implementing hemodynamic monitoring and judicious use of vasodilators like nitroglycerin, while avoiding excessive preload reduction which can compromise cardiac output. Non-invasive ventilation (NIV) may be beneficial in select patients with respiratory distress. Learn more about the latest guidelines for managing acute HFpEF exacerbations.
Diagnosing acute HFpEF in patients with comorbidities like COPD and obesity can be challenging due to overlapping symptoms. Dyspnea, which is a hallmark of acute HFpEF, is also common in both COPD and obesity. Pitfalls include attributing dyspnea solely to the underlying respiratory condition without considering cardiac dysfunction. Physical exam findings can also be misleading. Furthermore, obesity can make assessment of jugular venous pressure and heart sounds more difficult. BNP and NT-proBNP, while helpful, can be elevated in both HFpEF and COPD, requiring careful interpretation. Imaging modalities like echocardiography and chest X-ray are crucial for accurate diagnosis. Consider implementing a multidisciplinary approach involving cardiology and pulmonology to avoid misdiagnosis and optimize patient outcomes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.